The study also opens the door to new kinds of treatments that do not rely solely on antibiotics. Some of the surviving bacteria are fragile in specific ways, especially in their outer membranes.
Oncology and tackling chronic issues like obesity are still the big drivers for growth in the biotech world. Combining ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback